Disease Areas:
Chronic CoughDevice Types:
VitaloJAKDOI:
10.1007/s00408-026-00913-yThis post hoc analysis of the PROCOUGH study assessed whether type 2 inflammatory biomarkers predict treatment response and cough control in chronic cough. The VitaloJAK™ ambulatory cough monitor was used to objectively measure 24-hour cough frequency before and after treatment, enabling evaluation of cough outcomes.
